{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T10:42:17Z","timestamp":1769942537301,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.ejpb.2009.04.012","type":"journal-article","created":{"date-parts":[[2009,5,14]],"date-time":"2009-05-14T05:11:27Z","timestamp":1242277887000},"page":"115-120","source":"Crossref","is-referenced-by-count":60,"title":["A comparative study of different release apparatus in generating in vitro\u2013in vivo correlations for extended release formulations"],"prefix":"10.1016","volume":"73","author":[{"given":"N.","family":"Fotaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Aivaliotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Dressman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fischbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Hempenstall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Reppas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2009.04.012_bib1","unstructured":"FDA (Food and Drug Administration), Center for Drug Evaluation and Research (CDER), Guidance for Industry Extended Release Oral Dosage Forms: Development, Evaluation, and Application of In Vitro\/In Vivo Correlations, 1997."},{"key":"10.1016\/j.ejpb.2009.04.012_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0168-3659(01)00268-1","article-title":"Regulatory perspectives on in vitro (dissolution)\/in vivo (bioavailability) correlations","volume":"72","author":"Uppoor","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2009.04.012_bib3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1211\/0022357056172","article-title":"Site-specific release of anti-inflammatory drugs in the gastrointestinal tract: an in vitro model","volume":"57","author":"Klein","year":"2005","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2009.04.012_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejps.2004.10.003","article-title":"In vitro vs. canine data for predicting input profiles of isosorbide-5-mononitrate from oral extended release products on a confidence interval basis","volume":"24","author":"Fotaki","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2009.04.012_bib5","unstructured":"E. Jantratid, V. De Maio, E. Ronda, V. Mattavelli, J. Dressman, In vitro correlation analysis of modified release diclofenac sodium pellets, AAPS Annual Meeting, San Diego CA, USA, 2007."},{"key":"10.1016\/j.ejpb.2009.04.012_bib6","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jconrel.2008.06.014","article-title":"Use of the BioDis to generate a physiologically relevant IVIVC","volume":"130","author":"Klein","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2009.04.012_bib7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ejps.2005.07.004","article-title":"Canine vs. in vitro data for predicting input profiles of L-sulpiride after oral administration","volume":"26","author":"Fotaki","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2009.04.012_bib8","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/jps.2600840804","article-title":"USP dissolution apparatus 3 (reciprocating cylinder): instrument parameter effects on drug release from sustained release formulations","volume":"84","author":"Rohrs","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2009.04.012_bib9","first-page":"62","article-title":"Drug release profiles of swellable hydrocolloid formulations: USP apparatus 2 versus apparatus 3, in vitro correlation","volume":"22","author":"Altaf","year":"1998","journal-title":"Pharm. Technol."},{"key":"10.1016\/j.ejpb.2009.04.012_bib10","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1081\/DDC-100102236","article-title":"Investigation of prandial effects on hydrophilic matrix tablets","volume":"25","author":"Abrahamsson","year":"1999","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2009.04.012_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijpharm.2004.12.024","article-title":"Release characterization of dimenhydrinate from an eroding and swelling matrix: selection of appropriate dissolution apparatus","volume":"293","author":"Missaghi","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2009.04.012_bib12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/03639040500216410","article-title":"In vitro and in vivo evaluation of two extended release preparations of combination metformin and glipizide","volume":"31","author":"Defang","year":"2005","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2009.04.012_bib13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejpb.2008.05.029","article-title":"Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses","volume":"70","author":"Garbacz","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2009.04.012_bib14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1081\/DDC-100101287","article-title":"Osmotically controlled oral drug delivery","volume":"26","author":"Verma","year":"2000","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2009.04.012_bib15","unstructured":"N. Fotaki, In vitro release data vs. in vivo canine data for the prediction of gastrointestinal absorption of drug, Ph.D Thesis, National & Kapodistrian University of Athens, Athens, Greece, 2004."},{"key":"10.1016\/j.ejpb.2009.04.012_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/03639048709040169","article-title":"The effect of hydrodynamic conditions and delivery orifice size on the rate of drug release from the elementary osmotic pump system","volume":"13","author":"Ramadan","year":"1987","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2009.04.012_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.2042-7158.1984.tb02978.x","article-title":"The ionization of b-adrenoceptor agonists: a method for unravelling ionization schemes","volume":"36","author":"Ijzerman","year":"1984","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2009.04.012_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-5173(03)00129-7","article-title":"The human bronchial epithelial cell line 16HBE14o \u2013 as a model system of the airways for studying drug transport","volume":"257","author":"Forbes","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2009.04.012_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2004.03.001","article-title":"Classification of orally administered drugs on the World Health Organization model list of essential medicines according to the biopharmaceutics classification system","volume":"58","author":"Lindenberg","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2009.04.012_bib20","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1023\/A:1018907527253","article-title":"Albendazole generics \u2013 a comparative in vitro study","volume":"16","author":"Galia","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2009.04.012_bib21","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1023\/A:1011910801212","article-title":"Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs","volume":"15","author":"Galia","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2009.04.012_bib22","unstructured":"USP, United States Pharmacopeial Convention, Inc., The United States Pharmacopeia (USP 24), Rockville MD, 2000."},{"key":"10.1016\/j.ejpb.2009.04.012_bib23","unstructured":"S. Klein, Biorelevant Dissolution Test Methods for Modified Release Dosage Forms, Doctoral Thesis, University of Frankfurt, Shaker-Verlag, Aachen, 2005."},{"key":"10.1016\/j.ejpb.2009.04.012_bib24","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/BF02456001","article-title":"Pharmacokinetics and absolute bioavailability of salbutamol in healthy adult volunteers","volume":"32","author":"Goldstein","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejpb.2009.04.012_bib25","first-page":"491","article-title":"In vivo\u2013in vitro correlation of salbutamol release from a controlled release osmotic pump delivery system","volume":"13","author":"Civiale","year":"1991","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2009.04.012_bib26","series-title":"Primer of Biostatistics","author":"Glanz","year":"1997"},{"key":"10.1016\/j.ejpb.2009.04.012_bib27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1023\/A:1011071401306","article-title":"Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration","volume":"18","author":"Nicolaides","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2009.04.012_bib28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0378-5173(00)00399-9","article-title":"Omar gamma-scintigraphic study of the gastrointestinal transit and in vivo dissolution of a controlled release diclofenac sodium formulation in xanthan gum matrices","volume":"201","author":"Billa","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2009.04.012_bib29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0169-409X(00)00135-6","article-title":"The role of gamma scintigraphy in oral drug delivery","volume":"46","author":"Wilding","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2009.04.012_bib30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0939-6411(03)00141-3","article-title":"Comparison of simulated cumulative drug vs. time data sets with indices","volume":"56","author":"Vertzoni","year":"2003","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2009.04.012_bib31","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1211\/0022357023583","article-title":"Influence of dissolution media composition on drug release and in-vitro\/in-vivo correlation for paracetamol matrix tablets prepared with novel carbomer polymers","volume":"56","author":"Parojcic\u00b4","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2009.04.012_bib32","series-title":"Pharmaceutical Dissolution Testing","first-page":"127","article-title":"Physiological parameters relevant to dissolution testing: hydrodynamic considerations","author":"Diebold","year":"2005"},{"key":"10.1016\/j.ejpb.2009.04.012_bib33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0378-5173(00)00415-4","article-title":"Predicting dissolution via hydrodynamics: salicylic acid tablets in flow-through cell dissolution","volume":"201","author":"Cammarn","year":"2000","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964110900143X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964110900143X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T18:50:29Z","timestamp":1545245429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964110900143X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S093964110900143X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2009.04.012","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}